Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma

Ruiqi Liu, Tongsen Zheng, Meng Zhou et al.|Cancer Letters|2018

Cited by 144